This volume encompasses the field of allergic disease and asthma during the perinatal period, including the medical and obstetrical management of the pregnant woman, and prevention and treatment in her young child - providing a single authoritative source for the current knowlege on this topic. hormonal and immunological changes, pulmonary physiology and determinants of foetal oxygenation; explores avoidance measures, immunotherapy, psychological care and pharmacological management, including gestational safety data on specific allergy and asthma medications, and medicolegal considerations; presents medical and obstetrical treatment guidelines from several perspectives; covers the relationships to pregnancy and gestational management of other allergic or related conditions, such as rhinitis, sinusitis, anaphylaxis, cutaneous diseases and adverse drug reactions; and reviews genetic and environmental factors in the development of allergy in infancy, the natural history of allergy and asthma during childhood, and prospects for prevention of allergy in infancy.

This state-of-the-art volume explores the interrelationships between asthma, atopic illnesses, immunological diseases, and pregnancy, elucidates potential effects of specific treatments, and discusses optimal preventive, diagnostic, and management measures for ensuring the well-being of the pregnant woman and her fetus or infant. Covers gestational asthma, anaphylaxis, rhinosinusitis, urticaria/angioedema, atopic dermatitis, systemic lupus erythematosus, rheumatoid arthritis, HIV infection, immune deficiency states, and other conditions-including immunological factors leading to fetal loss! Written by more than 60 internationally recognized experts, Asthma and Immunological Diseases in Pregnancy and Early Infancy introduces for the first time medicolegal considerations when prescribing drugs during the perinatal period psychological aspects of gestational care animal and human data on the use of specific medications obstetrical management of the asthmatic patient maternal immune deficiency Along with updated and detailed perspectives on topics, such as allergy diagnosis and treatment immunologically mediated adverse drug reactions genetic and environmental bases of allergy development in infancy natural history and prevention of asthma and allergy in childhood the interrelationship between asthma and pregnancy and more!

This issue of Immunology and Allergy Clinics is devoted to Asthma in Childhood and is Guest Edited by Drs. Leonard Bacharier and Theresa Guilbert. Articles in this outstanding issue include: Inception and Natural History of Pediatric Asthma; Recent Diagnosis Techniques in Pediatric Asthma; Management / co-morbidities for Preschool-aged Children with Asthma; Management/ co-morbidities for School-aged Children with Asthma; Effects of the Environment on Disease Activity; New Advances of Self-Management/Adherence Monitoring and Management in Pediatric Asthma; Severe Asthma in Early Childhood; Inner-city Asthma in Early Childhood; Personalized Medicine and Pediatric Asthma; Prevention in Pediatric Asthma; Asthma in the Schools; and New Directions in Pediatric Asthma.

With insight and research from world-renowned experts, this book provides specific approaches to diagnosis and treatment, addressing pharmacologic and non-pharmacologic management. Specific conditions examined include asthma, rhinitis and sinusitis, anaphylaxis, atopic and contact dermatitis, urticaria and angioedema, hereditary angioedema, drug allergies, and primary immune deficiency. An overview of obstetric management of the high risk asthmatic and allergic patient is provided, and the book concludes with a discussion of the prevention of asthma and allergic diseases during childhood.

Chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease, kill more than 4 million people every year, and affect hundreds of millions more. These diseases erode the health and well-being of the patients and have a negative impact on families and societies. This report raises awareness of the huge impact of chronic respiratory diseases worldwide, and highlights the risk factors as well as ways to prevent and treat these diseases.

Over the past 20 years, public concerns have grown in response to the apparent rising prevalence of food allergy and related atopic conditions, such as eczema. Although evidence on the true prevalence of food allergy is complicated by insufficient or inconsistent data and studies with variable methodologies, many health care experts who care for patients agree that a real increase in food allergy has occurred and that it is unlikely to be due simply to an increase in awareness and better tools for diagnosis. Many stakeholders are concerned about these increases, including the general public, policy makers, regulatory agencies, the food industry, scientists, clinicians, and especially families of children and young people suffering from food allergy. At the present time, however, despite a mounting body of data on the prevalence, health consequences, and associated costs of food allergy, this chronic disease has not garnered the level of societal attention that it warrants. Moreover, for patients and families at risk, recommendations and guidelines have not been clear about preventing exposure or the onset of reactions or for managing this disease. Finding a Path to Safety in Food Allergy examines critical issues related to food allergy, including the prevalence and severity of food allergy and its impact on affected individuals, families, and communities; and current understanding of food allergy as a disease, and in diagnostics, treatments, prevention, and public policy. This report seeks to: clarify the nature of the disease, its causes, and its current management; highlight gaps in knowledge; encourage the implementation of management tools at many levels and among many stakeholders; and delineate a roadmap to safety for those who have, or are at risk of developing, food allergy, as well as for others in society who are responsible for public health.

This COMA report reviews available evidence linking dietary folate and folic acid with human health. It is concerned particularly with the need for adequate intakes of folate at the time of conception to reduce the risk of a pregnancy being affected by neural tube defect (NTD).